Distance to neurologist, PCP may explain Alzheimer’s disease disparities
Apr 05, 2024
Non-Hispanic American Indian and/or Alaska Native and Hispanic decedents have to travel further to neurologist than non-Hispanic whites.
Higher pancreatic fat percentage linked to lower cognition in men
Feb 27, 2024
Higher pancreatic fat was linked to lower cognition and brain volumes in middle-aged men at high risk for Alzheimer’s disease.
Monoclonal antibodies provide small benefits in Alzheimer’s disease
Jan 26, 2024
Harms include increased risks for amyloid-related imaging abnormalities (ARIA)-edema, ARIA-hemorrhage and symptomatic ARIA-edema.
Light therapy aids psychobehavioral symptoms with Alzheimer’s disease
Dec 08, 2023
Significant benefits were seen for sleep efficacy, depression and agitation.
Whole grain consumption linked to slower global cognitive decline
Nov 22, 2023
For African Americans, those in the highest quintile of whole grain consumption had slower declines in global cognition, perceptual speed and episodic memory.
High BP visit-to-visit variability linked to dementia risk in late life
Oct 31, 2023
Higher blood pressure variability was not associated with higher lifetime dementia risk at age 60, 70 or 80 years.
Georgia to be first state to let pharmacies sell low-dose cannabis
Oct 23, 2023
Meanwhile, the sale of marijuana is still illegal on a federal level
Composite inflammatory biomarker linked to dementia risk
Jul 21, 2023
Small but significant associations were seen between elevated biomarker levels and worsened cognitive performance.
Solanezumab does not slow cognitive decline in preclinical Alzheimer’s disease
Jul 19, 2023
The mean change in Preclinical Alzheimer Cognitive Composite score not significantly different at 240 weeks with solanezumab or placebo.
Donanemab slows clinical progression in early Alzheimer’s disease
Jul 17, 2023
The drug slows clinical progression at 76 weeks for those with low/medium tau and the combined low/medium and high tau pathology population.